Double‐Blind Randomized Trial of the Effect of Ticlopidine in Arteriovenous Fistulas for Hemodialysis

Artificial Organs

Volumn 9, Issue 1, 1985, Pages 61-63

  Fiskerstrand, C E ^a   Thompson, I W ^a   Burnet, M E ^a   Williams, P ^a   Anderton, J L ^a  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

Arteriovenous access; Hemodialysis; Ticlopidine

Indexed keywords

ADENOSINE DIPHOSPHATE; PLACEBO; TICLOPIDINE;

ARTERIOVENOUS FISTULA; BLOOD AND HEMOPOIETIC SYSTEM; CARDIOVASCULAR SYSTEM; CLINICAL ARTICLE; DRUG THERAPY; HEMODIALYSIS; HUMAN; KIDNEY; PERIPHERAL VASCULAR SYSTEM; THERAPY; THROMBOCYTE AGGREGATION;

ANTICOAGULANTS; ARTERIOVENOUS SHUNT, SURGICAL; CLINICAL TRIALS; DOUBLE-BLIND METHOD; GRAFT OCCLUSION, VASCULAR; HUMANS; RENAL DIALYSIS; THIOPHENES; THROMBOSIS; TICLOPIDINE;

BRESCIA; FISTULA;

EID: 0022390491     PISSN: 0160564X     EISSN: 15251594     Source Type: Journal    
DOI: 10.1111/j.1525-1594.1985.tb04349.x     Document Type: Article

References (5)

1. Effects of Ticlopidine, a new platelet inhibitor in man
2. Ticlopidine— an antiplatelet drug: effects in human volunteers
3. Biological control of antiaggregating drugs. Application to Ticlopidine
4. Antiaggregatory physiological and clinical effects of Ticlopidine in subjects with peripheral atherosclerosis
5. Antithrombotic therapy with Ticlopidine in chronic renal failure patients on maintenance haemodialysis—a multicenter collaborative double‐blind study